National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Emory Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia.
Fertil Steril. 2020 Feb;113(2):354-363.e1. doi: 10.1016/j.fertnstert.2019.09.035.
OBJECTIVE: To evaluate the effectiveness of intracytoplasmic sperm injection (ICSI) in improving fertilization rates compared to conventional in vitro fertilization rates (IVF) among women aged ≥38 years with a non-male factor diagnosis. DESIGN: Systematic review and meta-analysis. SETTING: Not applicable. PATIENT(S): Women aged ≥38 years with a non-male factor diagnosis receiving IVF or ICSI. INTERVENTION(S): A systematic review of databases including PubMed and Embase was performed. Study protocol was registered at the International Prospective Register of Systematic Reviews. Studies were selected if they compared fertilization rates from ICSI with those from conventional IVF among women aged ≥38 years with a non-male factor infertility diagnosis. A random effects model was used. Meta-analysis of Observational Studies in Epidemiology guidelines were applied. MAIN OUTCOME MEASURE(S): Fertilization rate. RESULTS: Seven studies including 8796 retrieved oocytes (ICSI: 4,369; IVF: 4,427) with mean female age ≥38 years met the inclusion criteria. There was no significant difference in fertilization rates between ICSI and conventional IVF (relative risk [RR] 0.99, 95% confidence interval [CI] 0.93-1.06; P = .8). Heterogeneity was observed between studies (I = 58.2; P < .05). Heterogeneity was significant (I = 57.1; P < .05) when cycles with prior fertilization failure were excluded; however, when analysis was restricted to poor responders (RR 1.01, 95% CI 0.97-1.05; P = .6), heterogeneity was no longer significant (I = 0.0; P = .5). CONCLUSIONS: No difference was found in fertilization rates between conventional IVF and ICSI. Further studies are needed to assess the impact of ICSI in this population, controlling for other indications such as preimplantation genetic testing.
目的:评估胞浆内单精子注射(ICSI)在改善受精率方面相对于非男性因素诊断的≥38 岁女性常规体外受精(IVF)的效果。
设计:系统评价和荟萃分析。
设置:不适用。
患者:非男性因素诊断且接受 IVF 或 ICSI 的≥38 岁女性。
干预措施:对包括 PubMed 和 Embase 在内的数据库进行系统回顾。研究方案在国际前瞻性系统评价注册处进行了注册。如果研究比较了≥38 岁非男性因素不孕诊断的女性中 ICSI 与常规 IVF 的受精率,则选择该研究。使用随机效应模型。应用观察性研究的荟萃分析流行病学指南。
主要观察指标:受精率。
结果:纳入的 7 项研究共包括 8796 个卵母细胞(ICSI:4369 个;IVF:4427 个),平均女性年龄≥38 岁。ICSI 和常规 IVF 的受精率无显著差异(相对风险 [RR] 0.99,95%置信区间 [CI] 0.93-1.06;P =.8)。研究之间存在异质性(I = 58.2;P <.05)。当排除受精失败的周期时,异质性显著(I = 57.1;P <.05);然而,当分析仅限于反应不良者时(RR 1.01,95%CI 0.97-1.05;P =.6),异质性不再显著(I = 0.0;P =.5)。
结论:常规 IVF 和 ICSI 之间的受精率没有差异。需要进一步的研究来评估 ICSI 在该人群中的影响,同时控制其他指征,如植入前遗传检测。
Cochrane Database Syst Rev. 2019-11-20
Acta Obstet Gynecol Scand. 2024-1
J Gynecol Obstet Hum Reprod. 2021-9
Eur J Obstet Gynecol Reprod Biol. 2014-7
Acta Obstet Gynecol Scand. 2024-1
J Assist Reprod Genet. 2023-10
Hum Reprod. 2016-7
Clin Exp Obstet Gynecol. 2012